类型2的kalreticulin突变激活ATF6,以促进BCL-xL介导的存活在骨髓增殖性瘤中
Nicole S Arellano1,2, William L Heaton1, Mirielle C Nauman3
1Division of Hematology and Hematological Malignancies, The University of Utah, Salt Lake City, UT.
Blood
|May 22, 2025
概括
卡尔雷丘林 (CALR) 类型2突变激活了ATF6途径的展开蛋白质反应 (UPR) 由于失去了陪伴者功能. CALRins5细胞依赖ATF6生存,BCL-XL被确定为一个关键目标.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 卡莱特库林 (CALR) 突变在骨髓增殖性瘤中很常见,被分类为1型 (CALRdel52) 或2型 (CALRins5).
- 这两种突变类型都通过激活MPL受体引起功能增益 (GOF).
- 与CALRins5不同的是,CALRdel52突变诱导结合的功能丧失 (LOF),激活未折叠蛋白响应 (UPR) 的IRE1/XBP1通路.
研究的目的:
- 为了调查CALRins5突变是否激活不同的UPR通路.
- 为了确定CALRins5-介导的UPR激活是否也由于突变类型特定的LOF.
- 在UPR中确定CALRins5突变的下游目标和依赖性.
主要方法:
- 在携带 CALRins5 突变的细胞中对 UPR 途径激活的分析.
- 调查CALR护送功能及其与CALRins5突变C终端的相互作用.
- 对ATF6成长途径的细胞依赖性评估和ATF6转录标的识别.
主要成果:
- CALRins5突变激活了UPR的激活转录因子6 (ATF6) 途径.
- 这种激活是由 CALR 伴侣功能中的 LOF 引起的,特别是由于 CALRins5 突变 C 末端对残留物 H170 的干扰.
- CALRins5细胞在细胞因子独立生长方面部分依赖ATF6,B细胞淋巴瘤超大 (BCL-XL) 被确定为支持生存的ATF6点.
结论:
- CALRins5突变通过受损的CALR伴侣功能独特地激活ATF6 UPR通路.
- ATF6通路及其点BCL-XL对CALRins5-突变细胞的生存至关重要.
- 这些发现揭示了骨髓增殖性瘤中不同CALR突变类型的独特UPR通路依赖性.
相关概念视频
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K


